Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
作者机构:State Key Laboratory of Molecular Engineering of PolymersDepartment of Macromolecular ScienceFudan UniversityShanghai 200433China Institute of Molecular Materials and DevicesFudan UniversityShanghai 200433China
出 版 物:《Chinese Chemical Letters》 (中国化学快报(英文版))
年 卷 期:2024年第35卷第3期
页 面:66-75页
核心收录:
学科分类:1002[医学-临床医学] 081704[工学-应用化学] 07[理学] 08[工学] 0817[工学-化学工程与技术] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 070302[理学-分析化学] 0703[理学-化学] 10[医学]
基 金:supported by the National Key R&D Program of China(No.2021YFC2301100) the Strategic Priority Research Program of the Chinese Academy of Sciences(No.XDB30000000) the National Natural Science Foundation of China(No.61890940) the Chongqing Bayu Scholar Program(No.DP2020036) Program of Shanghai Academic Research Leaders(No.23XD1420200) Fudan University
主 题:COVID-19 Point-of-care testing platforms Nucleic acid detection Asymptomatic infection Biosensors
摘 要:The outbreak of COVID-19 has drawn great attention around the ***-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation *** particular,the emergence of asymptomatic infections has made the epidemic even more ***,early diagnosis and timely management of suspected cases are essential measures to control the spread of the *** simple,portable,and accurate diagnostic techniques for SARS-CoV-2 is the key to epidemic *** advantages of point-of-care testing technology make it play an increasingly important role in viral detection and *** review summarizes the point-of-care testing platforms developed by nucleic acid detection,immunological detection,and nanomaterial-based biosensors ***,this paper provides a prospect for designing future highly accurate,cheap,and convenient SARS-CoV-2 diagnostic technology.